95 related articles for article (PubMed ID: 3596045)
1. Mantoux, DNCB test, peripheral blood phagocyte activity and serum immunoglobulin levels in BCG vaccination treatment of lung tumor patients.
Prugberger E; Hegyi P; Drinóczy M
Dev Biol Stand; 1986; 58 ( Pt A)():395-9. PubMed ID: 3596045
[No Abstract] [Full Text] [Related]
2. [Immunotherapy with BCG in pulmonary tumors].
Tanzj PL
Minerva Med; 1976 Dec; 67(63):4167-72. PubMed ID: 1018810
[TBL] [Abstract][Full Text] [Related]
3. The lack of relationship between serum content of MBL, sCD14, anti-PPD and anti-Hsp65 IgG and ingestion of Mycobacterium bovis BCG bacilli by phagocytes.
Paziak-Domańska B; Bonar A; Kowalewicz-Kulbat M; Klink M; Kowalski M; Karhukorpi J; Karttunen R; Jurkiewicz M; Rózalska B; Rudnicka W
Arch Immunol Ther Exp (Warsz); 2002; 50(5):337-44. PubMed ID: 12455868
[TBL] [Abstract][Full Text] [Related]
4. [The importance of the negative Mantoux Test in malignant diseases and possibilities of its prevention with BCG vaccination].
Zatriqi A; Haxhijaha S; Shabani A; Bukoshi B; Kandić Z
Med Pregl; 1979; 32(11-12):531-7. PubMed ID: 547167
[No Abstract] [Full Text] [Related]
5. [Activation of natural antitumor resistance in cancer patients during a delayed hypersensitivity reaction].
Gordienko SM; Novichev AP; Avdiunicheva OE; Churilova LA
Vopr Onkol; 1988; 34(5):572-6. PubMed ID: 3381499
[TBL] [Abstract][Full Text] [Related]
6. [Tumor immunologic aspects of lung cancer treatment].
Nilsson B
Lakartidningen; 1979 May; 76(20):1933-4. PubMed ID: 449470
[No Abstract] [Full Text] [Related]
7. Experience with BCG vaccination treatment in lung tumour patients.
Prugberger E; Hegyi P; Drinóczy M
Dev Biol Stand; 1986; 58 ( Pt A)():457-60. PubMed ID: 3297876
[No Abstract] [Full Text] [Related]
8. [Active nonspecific immunotherapy combined with surgical treatment of lung carcinoma].
Langer J
Pneumonol Pol; 1980 Feb; 48(2):121-7. PubMed ID: 6988811
[No Abstract] [Full Text] [Related]
9. Autologous x-irradiated tumour cells and percutaneous BCG in operable lung cancer.
Stack BH; McSwan N; Stirling JM; Hole DJ; Spilg WG; McHattie I; Elliott JA; Gillis CR; Turner MA; White RG
Thorax; 1982 Aug; 37(8):588-93. PubMed ID: 7179188
[TBL] [Abstract][Full Text] [Related]
10. Tuberculin reaction among healthy BCG vaccinated primary school, children in Nnewi, south eastern Nigeria.
Ifezulike CC; Ezechukwu CC; Egbonu I; Chukwuka JO
Niger J Clin Pract; 2005 Jun; 8(1):4-9. PubMed ID: 16392448
[TBL] [Abstract][Full Text] [Related]
11. Tuberculin conversion in children after BCG vaccination.
Kebede F
Ethiop Med J; 1993 Oct; 31(4):265-70. PubMed ID: 8287861
[TBL] [Abstract][Full Text] [Related]
12. Immunocompetence and its modification after BCG immunotherapy in patients with colon carcinoma.
Pacheco-Rupil B; Depiante M; Yantorno C; Nuñez P; Casadio B
Acta Gastroenterol Latinoam; 1980; 10(4):277-82. PubMed ID: 7270013
[TBL] [Abstract][Full Text] [Related]
13. In vitro lymphocyte responses and skin test reactivity following BCG vaccination.
Thomas JW; Clements D; Grzybowski S
Clin Exp Immunol; 1971 Nov; 9(5):611-23. PubMed ID: 5145430
[TBL] [Abstract][Full Text] [Related]
14. Four-year follow-up on the Albany experience with intrapleural BCG in lung cancer.
McKneally MF; Maver C; Lininger L; Kausel HW; McIlduff JB; Older TM; Foster ED; Alley RD
J Thorac Cardiovasc Surg; 1981 Apr; 81(4):485-92. PubMed ID: 7009993
[TBL] [Abstract][Full Text] [Related]
15. Results of the treatment of human lung cancer with BCG and the BCG-fraction F70 in relation to the treatment scheme and the clinical stage of the disease.
Hadziev S; Kavaklieva-Dimitrova J
J Hyg Epidemiol Microbiol Immunol; 1976; 20(1):36-42. PubMed ID: 944213
[No Abstract] [Full Text] [Related]
16. Prevalence of tuberculous infection and the impact of BCG vaccination on tuberculin testing among primary schoolchildren in Turkey.
Kösecik M; Emiroglu H; Tatli MM; Koc A; Atas A
Indian Pediatr; 2002 Apr; 39(4):362-5. PubMed ID: 11976465
[No Abstract] [Full Text] [Related]
17. [Specific changes in the phagocytic activity of leukocytes in children after BCG vaccination].
Sanakoeva LP
Probl Tuberk Bolezn Legk; 2003; (8):40-3. PubMed ID: 14524101
[TBL] [Abstract][Full Text] [Related]
18. BCG immunotherapy of rat tumors of defined immunogenicity.
Baldwin RW; Pimm MV
Natl Cancer Inst Monogr; 1973 Dec; 39():11-9. PubMed ID: 4595312
[No Abstract] [Full Text] [Related]
19. [Study of delayed hypersensitivity to tuberculin in 130 cancerous adults. Effects of BCG].
Israel L; Mawas C; Bouvrain A; Mannoni P; Sors C
Pathol Biol; 1967; 15(11):597-601. PubMed ID: 4860736
[No Abstract] [Full Text] [Related]
20. [Evaluation of tuberculin reactivity in different age groups with and without BCG vaccination].
Yildirim C; Küçük AI; Ongüt G; Oğünç D; Colak D; Mutlu G
Mikrobiyol Bul; 2009 Jan; 43(1):27-35. PubMed ID: 19334377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
